Literature DB >> 16167336

Increased radiation-induced apoptosis of Saos2 cells via inhibition of NFkappaB: a role for c-Jun N-terminal kinase.

Roman A Eliseev1, Michael J Zuscik, Edward M Schwarz, Regis J O'Keefe, Hicham Drissi, Randy N Rosier.   

Abstract

To elucidate the possible effect of NFkappaB on radioresistance, we used the osteosarcoma cell line Saos2, stably expressing the NFkappaB constitutive inhibitor, mIkappaB (Saos2-mIkappaB) or stably transfected with the empty vector (Saos2-EV). Ionizing radiation induced "intrinsic" apoptosis in Saos2-mIkappaB cells but not in Saos2-EV control cells, with intact NFkappaB activity. We find as expected, that this NFkappaB activity was enhanced following irradiation in the Saos2-EV control cells. On the other hand, inhibition of NFkappaB signaling in Saos2-mIkappaB cells led to the upregulation of the pro-apoptotic systems, such as Bax protein and c-Jun N-terminal Kinase (JNK)/c-Jun/AP1 signaling. Inhibition of NFkappaB resulted in decreased expression of the DNA damage protein GADD45beta, a known inhibitor of JNK. Subsequently, JNK activation of c-Jun/AP-1 proteins increased radiation-induced apoptosis in these mutants. Radiation-induced apoptosis in Saos2-mIkappaB cells was inhibited by the JNK specific inhibitor SP600125 as well as by Bcl-2 over-expression. Furthermore, release of cytochrome-c from mitochondria was increased and caspase-9 and -3 were activated following irradiation in Saos2-mIkappaB cells. Antisense inhibition of GADD45beta in Saos2-EV cells significantly enhanced apoptosis following irradiation. Our results demonstrate that radioresistance of Saos2 osteosarcoma cells is due to NFkappaB-mediated inhibition of JNK. Our study brings new insight into the mechanisms underlying radiation-induced apoptosis of osteosarcoma, and may lead to development of new therapeutic strategies against osteosarcoma. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167336     DOI: 10.1002/jcb.20607

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Disruption of ZAS3 in mice alters NF-kappaB and AP-1 DNA binding and T-cell development.

Authors:  Carl E Allen; John Richards; Natarajan Muthusamy; Herbert Auer; Yang Liu; Michael L Robinson; John A Barnard; Lai-Chu Wu
Journal:  Gene Expr       Date:  2007

Review 2.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

3.  Targeting radioresistant osteosarcoma cells with parthenolide.

Authors:  Daniel Zuch; An-Hoa Giang; Yuriy Shapovalov; Edward Schwarz; Randy Rosier; Regis O'Keefe; Roman A Eliseev
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

4.  Shock wave induces chronic renal lesion through activation of the nuclear factor kappa B signaling pathway.

Authors:  Xiang Li; Yuquan Xue; Dalin He; Xingfa Chen; Linlin Zhang
Journal:  World J Urol       Date:  2010-02-26       Impact factor: 4.226

5.  Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication.

Authors:  Yuriy Shapovalov; David Hoffman; Daniel Zuch; Karen L de Mesy Bentley; Roman A Eliseev
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

6.  Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase.

Authors:  Julie M Lowe; Hyukjin Cha; Qian Yang; Albert J Fornace
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

7.  Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression.

Authors:  Hamid Zand; Ali Rahimipour; Saideh Salimi; Sayed Mohammad Shafiee
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

8.  Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo.

Authors:  Xiang Hu; Yang Liu; Chunxia Qin; Zhenyu Pan; Jun Luo; Aixi Yu; Zhen Cheng
Journal:  Cancer Lett       Date:  2013-12-22       Impact factor: 8.679

9.  Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.

Authors:  Sabiha Abbas; Anindita Bhoumik; Russell Dahl; Stefan Vasile; Stan Krajewski; Nicholas D P Cosford; Ze'ev A Ronai
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

10.  Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect.

Authors:  An-Hoa Giang; Tamara Raymond; Paul Brookes; Karen de Mesy Bentley; Edward Schwarz; Regis O'Keefe; Roman Eliseev
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.